Synaptic dysfunction in disease and following injury in the developing and adult nervous system: Caveats in the choice of therapeutic intervention

Neuroscience and Biobehavioral Reviews

Volumn 31, Issue 8, 2007, Pages 1073-1087

  Gould, Thomas W ^a   Oppenheim, Ronald W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Motor neurons; Neurodegeneration; Neuron death; Synapse dysfunction

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; BAX GENE; BRAIN MITOCHONDRION; DEGENERATIVE DISEASE; GENE; GENE DELETION; HUMAN; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVE FIBER TRANSPORT; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INJURY; NEUROMUSCULAR SYNAPSE; NEUROPATHOLOGY; NOCICEPTIVE STIMULATION; NONHUMAN; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; REVIEW; SYNAPSE VESICLE; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL DEATH; DISEASE MODELS, ANIMAL; HUMANS; MICE; NERVOUS SYSTEM; NEUROMUSCULAR JUNCTION; PRESYNAPTIC TERMINALS;

EID: 36448939830     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2007.04.015     Document Type: Review

References (197)

1. Adlkofer K., Martini R., Aguzzi A., Zielasek J., Toyka K.V., and Suter U. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nature Genetics 11 (1995) 274-280
2. Aguayo A.J., Attiwell M., Trecarten J., Perkins S., and Bray G.M. Abnormal myelination in transplanted Trembler mouse Schwann cells. Nature 265 (1977) 73-75
3. Araki T., Sasaki Y., and Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305 (2004) 1010-1013
4. Artal-Sanz M., and Tavernarakis N. Proteolytic mechanisms in necrotic cell death and neurodegeneration. FEBS Letters 579 (2005) 3287-3296
5. Auer I.A., Schmidt M.L., Lee V.M., Curry B., Suzuki K., Shin R.W., Pentchev P.G., Carstea E.D., and Trojanowski J.Q. Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease. Acta Neuropathologica (Berlin) 90 (1995) 547-551
6. Balice-Gordon R.J., Chua C.K., Nelson C.C., and Lichtman J.W. Gradual loss of synaptic cartels precedes axon withdrawal at developing neuromuscular junctions. Neuron 11 (1993) 801-815
7. Bates G. Huntingtin aggregation and toxicity in Huntington's disease. Lancet 361 (2003) 1642-1644
8. Baurle J., Kranda K., and Frischmuth S. On the variety of cell death pathways in the Lurcher mutant mouse. Acta Neuropathologica (Berlin) 112 (2006) 691-702
9. Beal M.F., Kowall N.W., Ellison D.W., Mazurek M.F., Swartz K.J., and Martin J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321 (1986) 168-171
10. Bence N.F., Sampat R.M., and Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292 (2001) 1552-1555
11. Bingol B., and Schuman E.M. Synaptic protein degradation by the ubiquitin proteasome system. Current Opinion in Neurobiology 15 (2005) 536-541
12. Bishop D.L., Misgeld T., Walsh M.K., Gan W.B., and Lichtman J.W. Axon branch removal at developing synapses by axosome shedding. Neuron 44 (2004) 651-661
13. Bogan N., and Cabot J.B. Light and electron microscopic analyses of intraspinal axon collaterals of sympathetic preganglionic neurons. Brain Research 541 (1991) 241-251
14. Boillee S., Vande Velde C., and Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52 (2006) 39-59
15. Bowman A.B., Yoo S.Y., Dantuma N.P., and Zoghbi H.Y. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Human Molecular Genetics 14 (2005) 679-691
16. Brancolini C., Edomi P., Marzinotto S., and Schneider C. Exposure at the cell surface is required for gas3/PMP22 to regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases. Molecular Biology of the Cell 11 (2000) 2901-2914
17. Braun J.E., and Scheller R.H. Cysteine string protein, a DnaJ family member, is present on diverse secretory vesicles. Neuropharmacology 34 (1995) 1361-1369
18. Bredesen D.E., Rao M.V., and Mehlen P. Cell death in the nervous system. Nature 443 (2006) 796-802
19. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., and Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281 (1998) 1851-1854
20. Casari G., De Fusco M., Ciarmatori S., Zeviani M., Mora M., Fernandez P., De Michele G., Filla A., Cocozza S., Marconi R., Durr A., Fontaine B., and Ballabio A. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93 (1998) 973-983
21. Cavanaugh J.B. The significance of the "dying-back" process in experimental and human neurological disease. International Review of Experimental Pathology 3 (1964) 219-267
22. Cepeda C., Starling A.J., Wu N., Nguyen O.K., Uzgil B., Soda T., Andre V.M., Ariano M.A., and Levine M.S. Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF. Journal of Neuroscience Research 78 (2004) 855-867
23. Chan S.L., and Mattson M.P. Caspase and calpain substrates: roles in synaptic plasticity and cell death. Journal of Neuroscience Research 58 (1999) 167-190
24. Chandra S., Gallardo G., Fernández-Chacón R., Schluter O.M., and Sudhof T.C. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123 (2005) 383-396
25. Chen D.F., Schneider G.E., Martinou J.C., and Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385 (1997) 434-439
26. Chen S., Rio C., Ji R.R., Dikkes P., Coggeshall R.E., Woolf C.J., and Corfas G. Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss. Nature Neuroscience 6 (2003) 1186-1193
27. Ciechanover A., and Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40 (2003) 427-446
28. Clarke P.G.H., and Clarke S. Nineteenth century research on naturally occurring cell death and related phenomena. Anatomy and Embryology 193 (1996) 81-99
29. Cleveland D.W. From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. Neuron 24 (1999) 515-520
30. Coleman M.P. Axon degeneration mechanisms: commonality amid diversity. Nature Reviews Neuroscience 6 (2005) 889-898
31. Coleman M.P., and Perry V.H. Axon pathology in neurological disease: a neglected therapeutic target. Trends in Neuroscience 25 (2002) 532-537
32. Coleman M.P., Conforti L., Buckmaster E.A., Tarlton A., Ewing R.M., Brown M.C., Lyon M.F., and Perry V.H. An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proceedings of the National Academy of Sciences USA 95 (1998) 9985-9990
33. Collard J.F., Cote F., and Julien J.P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 375 (1995) 61-64
34. Collins T.J., Berridge M.J., Lipp P., and Bootman M.D. Mitochondria are morphologically and functionally heterogeneous within cells. EMBO Journal 21 (2002) 1616-1627
35. Conforti L., Tarlton A., Mack T.G., Mi W., Buckmaster E.A., Wagner D., Perry V.H., and Coleman M.P. A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proceedings of the National Academy of Sciences USA 97 (2000) 11377-11382
36. Cuervo A.M., and Dice J.F. How do intracellular proteolytic systems change with age?. Frontiers in Bioscience 3 (1998) d25-d43
37. Degenhardt K., Mathew R., Beaudoin B., Bray K., Anderson D., Chen G., Mukherjee C., Shi Y., Gelinas C., Fan Y., Nelson D.A., Jin S., and White E. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10 (2006) 51-64
38. Devaux J.J., and Scherer S.S. Altered ion channels in an animal model of Charcot-Marie-Tooth disease type IA. Journal of Neuroscience 25 (2005) 1470-1480
39. DiAntonio A., Haghighi A.P., Portman S.L., Lee J.D., Amaranto A.M., and Goodman C.S. Ubiquitination-dependent mechanisms regulate synaptic growth and function. Nature 412 (2001) 449-452
40. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., and Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277 (1997) 1990-1993
41. DiProspero N.A., Chen E.Y., Charles V., Plomann M., Kordower J.H., and Tagle D.A. Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements. Journal of Neurocytology 33 (2004) 517-533
42. Dusart I., Guenet J.L., and Sotelo C. Purkinje cell death: differences between developmental cell death and neurodegenerative death in mutant mice. Cerebellum 5 (2006) 163-173
43. Eaton B.A., Fetter R.D., and Davis G.W. Dynactin is necessary for synapse stabilization. Neuron 34 (2002) 729-741
44. Edgar J.M., McLaughlin M., Yool D., Zhang S.C., Fowler J.H., Montague P., Barrie J.A., McCulloch M.C., Duncan I.D., Garbern J., Nave K.A., and Griffiths I.R. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. Journal of Cell Biology 166 (2004) 121-131
45. Edinger A.L., and Thompson C.B. Death by design: apoptosis, necrosis and autophagy. Current Opinion in Cell Biology 16 (2004) 663-669
46. Ehlers M.D. Ubiquitin and synaptic dysfunction: ataxic mice highlight new common themes in neurological disease. Trends in Neuroscience 26 (2003) 4-7
47. Estanislao L.B., Morgello S., and Simpson D.M. Peripheral neuropathies associated with HIV and hepatitis C co-infection: a review. AIDS 19 (2005) S135-S139
48. Fabricius C., Berthold C.H., and Rydmark M. Axoplasmic organelles at nodes of Ranvier. II. Occurrence and distribution in large myelinated spinal cord axons of the adult cat. Journal of Neurocytology 22 (1993) 941-954
49. Fernández-Chacón R., and Sudhof T.C. Genetics of synaptic vesicle function: toward the complete functional anatomy of an organelle. Annual Review of Physiology 61 (1999) 753-776
50. Fernández-Chacón R., Wolfel M., Nishimune H., Tabares L., Schmitz F., Castellano-Munoz M., Rosenmund C., Montesinos M.L., Sanes J.R., Schneggenburger R., and Sudhof T.C. The synaptic vesicle protein CSP alpha prevents presynaptic degeneration. Neuron 42 (2004) 237-251
51. Ferreirinha F., Quattrini A., Pirozzi M., Valsecchi V., Dina G., Broccoli V., Auricchio A., Piemonte F., Tozzi G., Gaeta L., Casari G., Ballabio A., and Rugarli E.I. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. Journal of Clinical Investigation 113 (2004) 231-242
52. Ferri A., Sanes J.R., Coleman M.P., Cunningham J.M., and Kato A.C. Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Current Biology 13 (2003) 669-673
53. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., and Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Experimental Neurology 185 (2004) 232-240
54. Frey D., Schneider C., Xu L., Borg J., Spooren W., and Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. Journal of Neuroscience 20 (2000) 2534-2542
55. George R., and Griffin J.W. The proximo-distal spread of axonal degeneration in the dorsal columns of the rat. Journal of Neurocytology 23 (1994) 657-667
56. George R., and Griffin J.W. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Experimental Neurology 129 (1994) 225-236
57. 2+ sensor for transmitter release at a central synapse. Cell 79 (1994) 717-727
58. Geppert M., Bolshakov V.Y., Siegelbaum S.A., Takei K., De Camilli P., Hammer R.E., and Sudhof T.C. The role of Rab3A in neurotransmitter release. Nature 369 (1994) 493-497
59. Giese K.P., Martini R., Lemke G., Soriano P., and Schachner M. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71 (1992) 565-576
60. Gillingwater T.H., and Ribchester R.R. Compartmental neurodegeneration and synaptic plasticity in the Wld(s) mutant mouse. Journal of Physiology 534 (2001) 627-639
61. Gillingwater T.H., and Ribchester R.R. The relationship of neuromuscular synapse elimination to synaptic degeneration and pathology: insights from WldS and other mutant mice. Journal of Neurocytology 32 (2003) 863-881
62. Gillingwater T.H., Thomson D., Mack T.G., Soffin E.M., Mattison R.J., Coleman M.P., and Ribchester R.R. Age-dependent synapse withdrawal at axotomised neuromuscular junctions in Wld(s) mutant and Ube4b/Nmnat transgenic mice. Journal of Physiology 543 (2002) 739-755
63. Gindhart Jr. J.G., Desai C.J., Beushausen S., Zinn K., and Goldstein L.S. Kinesin light chains are essential for axonal transport in Drosophila. Journal of Cell Biology 141 (1998) 443-454
64. Gispert-Sanchez S., and Auburger G. The role of protein aggregates in neuronal pathology: guilty, innocent, or just trying to help?. Journal of Neural Transmission, Supplement 111-117 (2006)
65. Glass J.D., Brushart T.M., George E.B., and Griffin J.W. Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon. Journal of Neurocytology 22 (1993) 311-321
66. Glater E.E., Megeath L.J., Stowers R.S., and Schwarz T.L. Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. Journal of Cell Biology 173 (2006) 545-557
67. Golstein P., and Kroemer G. Cell death by necrosis: towards a molecular definition. Trends in Biochemical Sciences 32 (2007) 37-43
68. Gould T.W., and Oppenheim R.W. Neuronal death and rescue: neurotrophic factors and anti-apoptotic mechanisms. In: Selzer M., Clarke S., Cohen L., Duncan P., and Gage F. (Eds). Textbook of Neural Repair and Neurorehabilitation (2005), Cambridge University Press, Cambridge 271-292
69. Gould T.W., Buss R.R., Vinsant S., Prevette D., Sun W., Knudson C.M., Milligan C.E., and Oppenheim R.W. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. Journal of Neuroscience 26 (2006) 8774-8786
70. Guégan C., and Przedborski S. Programmed cell death in amyotrophic lateral sclerosis. Journal of Clinical Investigation 111 (2003) 153-161
71. Gunawardena S., and Goldstein L.S. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32 (2001) 389-401
72. Gunawardena S., and Goldstein L.S. Cargo-carrying motor vehicles on the neuronal highway: transport pathways and neurodegenerative disease. Journal of Neurobiology 58 (2004) 258-271
73. Guo X., Macleod G.T., Wellington A., Hu F., Panchumarthi S., Schoenfield M., Marin L., Charlton M.P., Atwood H.L., and Zinsmaier K.E. The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 47 (2005) 379-393
74. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
75. Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., Lalli G., Witherden A.S., Hummerich H., Nicholson S., Morgan P.J., Oozageer R., Priestley J.V., Averill S., King V.R., Ball S., Peters J., Toda T., Yamamoto A., Hiraoka Y., Augustin M., Korthaus D., Wattler S., Wabnitz P., Dickneite C., Lampel S., Boehme F., Peraus G., Popp A., Rudelius M., Schlegel J., Fuchs H., Hrabe de Angelis M., Schiavo G., Shima D.T., Russ A.P., Stumm G., Martin J.E., and Fisher E.M. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300 (2003) 808-812
76. Hanyu N., Oguchi K., Yanagisawa N., and Tsukagoshi H. Degeneration and regeneration of ventral root motor fibers in amyotrophic lateral sclerosis. Morphometric studies of cervical ventral roots. Journal of the Neurological Sciences 55 (1982) 99-115
77. Hegde A.N., and DiAntonio A. Ubiquitin and the synapse. Nature Reviews Neuroscience 3 (2002) 854-861
78. Hollenbeck P.J. The pattern and mechanism of mitochondrial transport in axons. Frontiers in Bioscience 1 (1996) d91-d102
79. Hollenbeck P.J., and Saxton W.M. The axonal transport of mitochondria. Journal of Cell Science 118 (2005) 5411-5419
80. Hoopfer E.D., McLaughlin T., Watts R.J., Schuldiner O., O'Leary D.D., and Luo L. Wlds protection distinguishes axon degeneration following injury from naturally occurring developmental pruning. Neuron 50 (2006) 883-895
81. Horvitz H.R. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Research 59 (1999) 1701s-1706s
82. Hurd D.D., and Saxton W.M. Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in Drosophila. Genetics 144 (1996) 1075-1085
83. Imai Y., and Takahashi R. How do Parkin mutations result in neurodegeneration?. Current Opinion in Neurobiology 14 (2004) 384-389
84. Irobi J., De Jonghe P., and Timmerman V. Molecular genetics of distal hereditary motor neuropathies. Human Molecular Genetics 13 Spec. No. 2 (2004) R195-R202
85. Jaarsma, D., Teuling, E., Hoogenraad, C.C., 2006. Neuron-specific expression of mutant SOD1 is sufficient to cause motoneuron disease in mice. SFN Abstracts 508.
86. 2+ regulators in neurotransmitter release. Neuron 24 (1999) 1003-1016
87. Joel D., Ayalon L., Tarrasch R., Veenman L., Feldon J., and Weiner I. Electrolytic lesion of globus pallidus ameliorates the behavioral and neurodegenerative effects of quinolinic acid lesion of the striatum: a potential novel treatment in a rat model of Huntington's disease. Brain Research 787 (1998) 143-148
88. Johnston J.A., Ward C.L., and Kopito R.R. Aggresomes: a cellular response to misfolded proteins. Journal of Cell Biology 143 (1998) 1883-1898
89. Julien J.P., Couillard-Despres S., and Meier J. Transgenic mice in the study of ALS: the role of neurofilaments. Brain Pathology 8 (1998) 759-769
90. Kamal A., Stokin G.B., Yang Z., Xia C.H., and Goldstein L.S. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 28 (2000) 449-459
91. Kamal A., Almenar-Queralt A., LeBlanc J.F., Roberts E.A., and Goldstein L.S. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414 (2001) 643-648
92. Karten B., Campenot R.B., Vance D.E., and Vance J.E. The Niemann-Pick C1 protein in recycling endosomes of presynaptic nerve terminals. Journal of Lipid Research 47 (2006) 504-514
93. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer 26 (1972) 239-257
94. King S.J., and Schroer T.A. Dynactin increases the processivity of the cytoplasmic dynein motor. Nature Cell Biology 2 (2000) 20-24
95. Klionsky D.J., and Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 290 (2000) 1717-1721
96. Klionsky D.J., Cregg J.M., Dunn Jr. W.A., Emr S.D., Sakai Y., Sandoval I.V., Sibirny A., Subramani S., Thumm M., Veenhuis M., and Ohsumi Y. A unified nomenclature for yeast autophagy-related genes. Developmental Cell 5 (2003) 539-545
97. Korhonen L., and Lindholm D. The ubiquitin proteasome system in synaptic and axonal degeneration: a new twist to an old cycle. Journal of Cell Biology 165 (2004) 27-30
98. Korsmeyer S.J. BCL-2 gene family and the regulation of programmed cell death. Cancer Research 59 (1999) 1693s-1700s
99. Kostic V., Jackson-Lewis V., de Bilbao F., Dubois-Dauphin M., and Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277 (1997) 559-562
100. Kroemer G., and Martin S.J. Caspase-independent cell death. Nature Medicine 11 (2000) 725-730
101. Kroemer G., Galluzzi L., and Brenner C. Mitochondrial membrane permeabilization in cell death. Physiological Reviews 87 (2007) 99-163
102. Kuznetsov S.A., Langford G.M., and Weiss D.G. Actin-dependent organelle movement in squid axoplasm. Nature 356 (1992) 722-725
103. LaMonte B.H., Wallace K.E., Holloway B.A., Shelly S.S., Ascano J., Tokito M., Van Winkle T., Howland D.S., and Holzbaur E.L. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34 (2002) 715-727
104. Lawson V.H., Gordon Smith A., and Bromberg M.B. Assessment of axonal loss in Charcot-Marie-Tooth neuropathies. Experimental Neurology 184 (2003) 753-757
105. Lehning E.J., Balaban C.D., Ross J.F., and LoPachin R.M. Acrylamide neuropathy. III. Spatiotemporal characteristics of nerve cell damage in forebrain. Neurotoxicology 24 (2003) 125-136
106. Levine B., and Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Developmental Cell 6 (2004) 463-477
107. Levine B., and Yuan J. Autophagy in cell death: an innocent convict?. Journal of Clinical Investigation 115 (2005) 2679-2688
108. Li J.Y., Plomann M., and Brundin P. Huntington's disease: a synaptopathy?. Trends in Molecular Medicine 9 (2003) 414-420
109. Li Z., Okamoto K., Hayashi Y., and Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119 (2004) 873-887
110. Lievens J.C., Woodman B., Mahal A., Spasic-Boscovic O., Samuel D., Kerkerian-Le Goff L., and Bates G.P. Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiology of Disease 8 (2001) 807-821
111. Lin M.T., and Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006) 787-795
112. Liu H.M., Yang L.H., and Yang Y.J. Schwann cell properties: 3 C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration. Journal of Neuropathology and Experimental Neurology 54 (1995) 487-496
113. Liu Y., Fallon L., Lashuel H.A., Liu Z., and Lansbury Jr. P.T. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 111 (2002) 209-218
114. Liu J., Lillo C., Jonsson P.A., Vande Velde C., Ward C.M., Miller T.M., Subramaniam J.R., Rothstein J.D., Marklund S., Andersen P.M., Brannstrom T., Gredal O., Wong P.C., Williams D.S., and Cleveland D.W. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43 (2004) 5-17
115. Lockshin R.A., and Williams C.W. Programmed cell death. II. Endocrine potentiation of the breakdown of intersegmental muscles of silkmoths. Journal of Insect Physiology 10 (1964) 643-649
116. LoPachin R.M., Schwarcz A.I., Gaughan C.L., Mansukhani S., and Das S. In vivo and in vitro effects of acrylamide on synaptosomal neurotransmitter uptake and release. Neurotoxicology 25 (2004) 349-363
117. Lunn E.R., Perry V.H., Brown M.C., Rosen H., and Gordon S. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. European Journal of Neuroscience 1 (1989) 27-33
118. Ly C.V., and Verstreken P. Mitochondria at the synapse. Neuroscientist 12 (2006) 291-299
119. Mack T.G., Reiner M., Beirowski B., Mi W., Emanuelli M., Wagner D., Thomson D., Gillingwater T., Court F., Conforti L., Fernando F.S., Tarlton A., Andressen C., Addicks K., Magni G., Ribchester R.R., Perry V.H., and Coleman M.P. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nature Neuroscience 4 (2001) 1199-1206
120. Martini R. The effect of myelinating Schwann cells on axons. Muscle and Nerve 24 (2001) 456-466
121. Masliah E., Mallory M., Alford M., DeTeresa R., Hansen L.A., McKeel Jr. D.W., and Morris J.C. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 56 (2001) 127-129
122. Mattson M.P., Keller J.N., and Begley J.G. Evidence for synaptic apoptosis. Experimental Neurology 153 (1998) 35-48
123. Mayer R.J., Lowe J., Lennox G., Doherty F., and Landon M. Intermediate filaments and ubiquitin: a new thread in the understanding of chronic neurodegenerative diseases. Progress in Clinical and Biological Research 317 (1989) 809-818
124. McCabe B.D., Hom S., Aberle H., Fetter R.D., Marques G., Haerry T.E., Wan H., O'Connor M.B., Goodman C.S., and Haghighi A.P. Highwire regulates presynaptic BMP signaling essential for synaptic growth. Neuron 41 (2004) 891-905
125. McIntire S.L., Jorgensen E., and Horvitz H.R. Genes required for GABA function in Caenorhabditis elegans. Nature 364 (1993) 334-337
126. Mi W., Beirowski B., Gillingwater T.H., Adalbert R., Wagner D., Grumme D., Osaka H., Conforti L., Arnhold S., Addicks K., Wada K., Ribchester R.R., and Coleman M.P. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. Brain 128 (2005) 405-416
127. Miller K.E., and Sheetz M.P. Axonal mitochondrial transport and potential are correlated. Journal of Cell Science 117 (2004) 2791-2804
128. Mitsumoto H., Kurahashi K., Jacob J.M., and McQuarrie I.G. Retardation of fast axonal transport in wobbler mice. Muscle and Nerve 16 (1993) 542-547
129. Miura H., Oda K., Endo C., Yamazaki K., Shibasaki H., and Kikuchi T. Progressive degeneration of motor nerve terminals in GAD mutant mouse with hereditary sensory axonopathy. Neuropathology and Applied Neurobiology 19 (1993) 41-51
130. Mizuno H., Shibayama H., Tanaka F., Doyu M., Sobue G., Iwata H., Kobayashi H., Yamada K., Iwai K., Takeuchi T., Hashimoto N., Ishihara R., Ibuki Y., Ogasawara S., and Ozeki M. An autopsy case with clinically and molecular genetically diagnosed Huntington's disease with only minimal non-specific neuropathological findings. Clinical Neuropathology 19 (2000) 94-103
131. Morris R.L., and Hollenbeck P.J. The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth. Journal of Cell Science 104 Pt. 3 (1993) 917-927
132. Naef R., and Suter U. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiology of Disease 6 (1999) 1-14
133. Neufeld E.F. Lysosomal storage diseases. Annual Review of Biochemistry 60 (1991) 257-280
134. Nguyen P.V., Marin L., and Atwood H.L. Synaptic physiology and mitochondrial function in crayfish tonic and phasic motor neurons. Journal of Neurophysiology 78 (1997) 281-294
135. Nicholson D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death and Differentiation 6 (1999) 1028-1042
136. Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R., Gillingwater T., Webb J., Skehel P., and Zatz M. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. American Journal of Human Genetics 75 (2004) 822-831
137. Notterpek L., Ryan M.C., Tobler A.R., and Shooter E.M. PMP22 accumulation in aggresomes: implications for CMT1A pathology. Neurobiology of Disease 6 (1999) 450-460
138. Parson S.H., Mackintosh C.L., and Ribchester R.R. Elimination of motor nerve terminals in neonatal mice expressing a gene for slow wallerian degeneration (C57Bl/Wlds). European Journal of Neuroscience 9 (1997) 1586-1592
139. Pasinelli P., Belford M.E., Lennon N., Bacskai B.J., Hyman B.T., Trotti D., and Brown Jr. R.H. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43 (2004) 19-30
140. Petersen A., Puschban Z., Lotharius J., NicNiocaill B., Wiekop P., O'Connor W.T., and Brundin P. Evidence for dysfunction of the nigrostriatal pathway in the R6/1 line of transgenic Huntington's disease mice. Neurobiology of Disease 11 (2002) 134-146
141. Pilling A.D., Horiuchi D., Lively C.M., and Saxton W.M. Kinesin-1 and dynein are the primary motors for fast transport of mitochondria in Drosophila motor axons. Molecular Biology of the Cell 17 (2006) 2057-2068
142. Pollin M.M., McHanwell S., and Slater C.R. The effect of age on motor neurone death following axotomy in the mouse. Development 112 (1991) 83-89
143. Prineas J. The pathogenesis of dying-back polyneuropathies. II. An ultrastructural study of experimental acrylamide intoxication in the cat. Journal of Neuropathology and Experimental Neurology 28 (1969) 598-621
144. Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L., Tokito M., Mann E., Floeter M.K., Bidus K., Drayna D., Oh S.J., Brown Jr. R.H., Ludlow C.L., and Fischbeck K.H. Mutant dynactin in motor neuron disease. Nature Genetics 33 (2003) 455-456
145. Raff M.C., Whitmore A.V., and Finn J.T. Axonal self-destruction and neurodegeneration. Science 296 (2002) 868-871
146. Ribchester R.R., Tsao J.W., Barry J.A., Asgari-Jirhandeh N., Perry V.H., and Brown M.C. Persistence of neuromuscular junctions after axotomy in mice with slow Wallerian degeneration (C57BL/WldS). European Journal of Neuroscience 7 (1995) 1641-1650
147. Rosahl T.W., Spillane D., Missler M., Herz J., Selig D.K., Wolff J.R., Hammer R.E., Malenka R.C., and Sudhof T.C. Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 375 (1995) 488-493
148. Rubinsztein D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443 (1997) 780-786
149. Sagot Y., Dubois-Dauphin M., Tan S.A., de Bilbao F., Aebischer P., Martinou J.C., and Kato A.C. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. Journal of Neuroscience 15 (1995) 7727-7733
150. Saigoh K., Wang Y.L., Suh J.G., Yamanishi T., Sakai Y., Kiyosawa H., Harada T., Ichihara N., Wakana S., Kikuchi T., and Wada K. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nature Genetics 23 (1999) 47-51
151. Samsam M., Mi W., Wessig C., Zielasek J., Toyka K.V., Coleman M.P., and Martini R. The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. Journal of Neuroscience 23 (2003) 2833-2839
152. Sang T.K., Li C., Liu W., Rodriguez A., Abrams J.M., Zipursky S.L., and Jackson G.R. Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis. Human Molecular Genetics 14 (2005) 357-372
153. Savill J., and Fadok V. Corpse clearance defines the meaning of cell death. Nature 407 (2000) 784-788
154. Schaefer A.M., Sanes J.R., and Lichtman J.W. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. Journal of Comparative Neurology 490 (2005) 209-219
155. Scherer S.S., Xu Y.T., Messing A., Willecke K., Fischbeck K.H., and Jeng L.J. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice. Journal of Neuroscience 25 (2005) 1550-1559
156. Schmitt-John T., Drepper C., Mussmann A., Hahn P., Kuhlmann M., Thiel C., Hafner M., Lengeling A., Heimann P., Jones J.M., Meisler M.H., and Jockusch H. Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse. Nature Genetics 37 (2005) 1213-1215
157. Schoch S., Deak F., Konigstorfer A., Mozhayeva M., Sara Y., Sudhof T.C., and Kavalali E.T. SNARE function analyzed in synaptobrevin/VAMP knockout mice. Science 294 (2001) 1117-1122
158. Schweichel J.U., and Merker H.J. The morphology of various types of cell death in prenatal tissues. Teratology 7 (1973) 253-266
159. 2+: a control point for apoptosis. Science 300 (2003) 135-139
160. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
161. Sima A.A. New insights into the metabolic and molecular basis for diabetic neuropathy. Cellular and Molecular Life Sciences 60 (2003) 2445-2464
162. Smith R.G., Siklos L., Alexianu M.E., Engelhardt J.I., Mosier D.R., Colom L., Habib Mohamed A., and Appel S.H. Autoimmunity and ALS. Neurology 47 (1996) S40-S45 discussion S45-S46
163. Sokol J., Blanchette-Mackie J., Kruth H.S., Dwyer N.K., Amende L.M., Butler J.D., Robinson E., Patel S., Brady R.O., Comly M.E., et al. Type C Niemann-Pick disease. Lysosomal accumulation and defective intracellular mobilization of low density lipoprotein cholesterol. Journal of Biological Chemistry 263 (1988) 3411-3417
164. Solary E., Eymin B., Droin N., and Haugg M. Proteases, proteolysis, and apoptosis. Cell Biology and Toxicology 14 (1998) 121-132
165. Son Y.J., and Thompson W.J. Schwann cell processes guide regeneration of peripheral axons. Neuron 14 (1995) 125-132
166. Speese S.D., Trotta N., Rodesch C.K., Aravamudan B., and Broadie K. The ubiquitin proteasome system acutely regulates presynaptic protein turnover and synaptic efficacy. Current Biology 13 (2003) 899-910
167. Spencer P.S., and Schaumburg H.H. A review of acrylamide neurotoxicity. Part I. Properties, uses and human exposure. Canadian Journal of Neurological Sciences 1 (1974) 143-150
168. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount
169. Stone J.D., Peterson A.P., Eyer J., Oblak T.G., and Sickles D.W. Neurofilaments are nonessential to the pathogenesis of toxicant-induced axonal degeneration. Journal of Neuroscience 21 (2001) 2278-2287
170. Stowers R.S., Megeath L.J., Gorska-Andrzejak J., Meinertzhagen I.A., and Schwarz T.L. Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein. Neuron 36 (2002) 1063-1077
171. Styers M.L., Kowalczyk A.P., and Faundez V. Intermediate filaments and vesicular membrane traffic: the odd couple's first dance?. Traffic 6 (2005) 359-365
172. Suter U., and Scherer S.S. Disease mechanisms in inherited neuropathies. Nature Reviews Neuroscience 4 (2003) 714-726
173. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., and Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of Neurology 30 (1991) 572-580
174. Ulzheimer J.C., Peles E., Levinson S.R., and Martini R. Altered expression of ion channel isoforms at the node of Ranvier in P0-deficient myelin mutants. Molecular and Cellular Neuroscience 25 (2004) 83-94
175. Vande Velde C., Garcia M.L., Yin X., Trapp B.D., and Cleveland D.W. The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease. Neuromolecular Medicine 5 (2004) 193-203
176. Varadi A., Johnson-Cadwell L.I., Cirulli V., Yoon Y., Allan V.J., and Rutter G.A. Cytoplasmic dynein regulates the subcellular distribution of mitochondria by controlling the recruitment of the fission factor dynamin-related protein-1. Journal of Cell Science 117 (2004) 4389-4400
177. Verpoorten N., De Jonghe P., and Timmerman V. Disease mechanisms in hereditary sensory and autonomic neuropathies. Neurobiology of Disease 21 (2006) 247-255
178. Verstreken P., Ly C.V., Venken K.J., Koh T.W., Zhou Y., and Bellen H.J. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 47 (2005) 365-378
179. Vijayakrishnan N., and Broadie K. Temperature-sensitive paralytic mutants: insights into the synaptic vesicle cycle. Biochemical Society Transactions 34 (2006) 81-87
180. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., and Richardson Jr. E.P. Neuropathological classification of Huntington's disease. Journal of Neuropathology and Experimental Neurology 44 (1985) 559-577
181. Walkley S.U. Cellular pathology of lysosomal storage disorders. Brain Pathology 8 (1998) 175-193
182. Wang Y.M., Gainetdinov R.R., Fumagalli F., Xu F., Jones S.R., Bock C.B., Miller G.W., Wightman R.M., and Caron M.G. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19 (1997) 1285-1296
183. Wang Q.J., Ding Y., Kohtz D.S., Mizushima N., Cristea I.M., Rout M.P., Chait B.T., Zhong Y., Heintz N., and Yue Z. Induction of autophagy in axonal dystrophy and degeneration. Journal of Neuroscience 26 (2006) 8057-8068
184. Warita H., Itoyama Y., and Abe K. Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene. Brain Research 819 (1999) 120-131
185. Watts R.J., Hoopfer E.D., and Luo L. Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system. Neuron 38 (2003) 871-885
186. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., and Korsmeyer S.J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292 (2001) 727-730
187. Wilson S.M., Bhattacharyya B., Rachel R.A., Coppola V., Tessarollo L., Householder D.B., Fletcher C.F., Miller R.J., Copeland N.G., and Jenkins N.A. Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease. Nature Genetics 32 (2002) 420-425
188. Wishart T.M., Parson S.H., and Gillingwater T.H. Synaptic vulnerability in neurodegenerative disease. Journal of Neuropathology and Experimental Neurology 65 (2006) 733-739
189. Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., and Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14 (1995) 1105-1116
190. Wrabetz L., Feltri M.L., Quattrini A., Imperiale D., Previtali S., D'Antonio M., Martini R., Yin X., Trapp B.D., Zhou L., Chiu S.Y., and Messing A. P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. Journal of Cell Biology 148 (2000) 1021-1034
191. Yamashima T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Progress in Neurobiology 62 (2000) 273-295
192. Yamazaki K., Wakasugi N., Tomita T., Kikuchi T., Mukoyama M., and Ando K. Gracile axonal dystrophy (GAD), a new neurological mutant in the mouse. Proceedings of the Society for Experimental Biology and Medicine 187 (1988) 209-215
193. Yin X., Kidd G.J., Pioro E.P., McDonough J., Dutta R., Feltri M.L., Wrabetz L., Messing A., Wyatt R.M., Balice-Gordon R.J., and Trapp B.D. Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals. Journal of Neuroscience 24 (2004) 3890-3898
194. Younkin S.G. Evidence that A beta 42 is the real culprit in Alzheimer's disease. Annals of Neurology 37 (1995) 287-288
195. Zhai Q., Wang J., Kim A., Liu Q., Watts R., Hoopfer E., Mitchison T., Luo L., and He Z. Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron 39 (2003) 217-225
196. Zhang Y., Gao J., Chung K.K., Huang H., Dawson V.L., and Dawson T.M. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proceedings of the National Academy of Sciences USA 97 (2000) 13354-13359
197. Zhao Y., Hegde A.N., and Martin K.C. The ubiquitin proteasome system functions as an inhibitory constraint on synaptic strengthening. Current Biology 13 (2003) 887-898